Open AccessSurvivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients
Author(s) -
Paul N. Span,
Fred C.G.J. Sweep,
Erwin T. Wiegerinck,
Vivianne C. G. TjanHeijnen,
Peggy Manders,
L.V.A.M. Beex,
Jaques B de Kok
Publication year - 2004
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2004.039149
Subject(s) - survivin , hazard ratio , breast cancer , medicine , oncology , proportional hazards model , estrogen receptor , univariate analysis , confidence interval , cancer , multivariate analysis
Results in previous qualitative studies of the association of the apoptosis inhibitor survivin with prognosis of breast cancer patients have been contradictory.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom